{"article_title": "Why is Gilead charging VA $40,000 for drug? (Opinion)", "article_keywords": ["va", "jeff", "miller", "company", "drug", "gilead", "40000", "hepatitis", "making", "opinion", "deserves", "veterans", "charging", "drugmaker"], "article_url": "http://www.cnn.com/2016/01/27/opinions/miller-gilead-drug-price/", "article_text": "Story highlights Jeff Miller: Drugmaker charging VA upward of $40,000 per patient to treat hepatitis C\n\nMiller calls price outrageous, especially since the company charges Egyptians far less\n\nU.S. Rep. Jeff Miller, R-Florida, is the chairman of the House Committee on Veterans' Affairs. The opinions expressed in this commentary are solely those of the author.\n\n(CNN) In America, honoring our veterans comes second nature to most citizens. That's because the overwhelming majority of our people understand that, if not for the service and sacrifice of those who have worn the uniform, the United States would not be the extraordinary place it is today.\n\nUnfortunately, this concept seems lost on the people at drugmaker Gilead Sciences.\n\nJeff Miller\n\nThe company is the maker of the hepatitis drug sofosbuvir, which can potentially cure hepatitis C, a chronic liver disease that affects about 3.2 million Americans, including nearly 200,000 veterans. The fact that Gilead is making this landmark medication available to consumers is an overwhelmingly positive development that deserves recognition.\n\nBut the way in which the company is picking and choosing who gets affordable access to the drug deserves condemnation.\n\nSofosbuvir doesn't come cheap -- that is, unless you live in countries such as Egypt, where Gilead is making the drug available for around $900 for the full 12-week regimen\n\nRead More", "article_metadata": {"description": "U.S. Rep. Jeff Miller asks why does drugmaker Gilead favors Egyptians over American veterans when it comes to treating hepatitis C.", "pubdate": "2016-01-27T19:32:22Z", "author": "Jeff Miller", "og": {"site_name": "CNN", "description": "U.S. Rep. Jeff Miller asks why does drugmaker Gilead favors Egyptians over American veterans when it comes to treating hepatitis C.", "pubdate": "2016-01-27T19:32:22Z", "title": "Why is Gilead charging VA $40,000 for drug? (Opinion)", "url": "http://www.cnn.com/2016/01/27/opinions/miller-gilead-drug-price/index.html", "image": "http://i2.cdn.turner.com/cnnnext/dam/assets/150702155744-09-major-federal-agencies-large-169.jpg", "type": "article"}, "section": "opinions", "fb": {"app_id": 80401312489}, "thumbnail": "http://i2.cdn.turner.com/cnnnext/dam/assets/150702155744-09-major-federal-agencies-large-169.jpg", "template-top": "opinions,art-img", "vr": {"canonical": "http://www.cnn.com/2016/01/27/opinions/miller-gilead-drug-price/index.html"}, "keywords": "opinions, Why is Gilead charging VA $40,000 for drug? (Opinion) - CNN.com", "lastmod": "2016-01-27T19:32:22Z", "twitter": {"card": "summary_large_image"}, "viewport": "width=device-width, initial-scale=1.0, minimum-scale=1.0"}, "_id": "\"57477af46914bd0286fd8547\"", "article_summary": "But the way in which the company is picking and choosing who gets affordable access to the drug deserves condemnation.\nUnfortunately, this concept seems lost on the people at drugmaker Gilead Sciences.\nStory highlights Jeff Miller: Drugmaker charging VA upward of $40,000 per patient to treat hepatitis CMiller calls price outrageous, especially since the company charges Egyptians far lessU.S. Rep. Jeff Miller, R-Florida, is the chairman of the House Committee on Veterans' Affairs.\nThe fact that Gilead is making this landmark medication available to consumers is an overwhelmingly positive development that deserves recognition.\nSofosbuvir doesn't come cheap -- that is, unless you live in countries such as Egypt, where Gilead is making the drug available for around $900 for the full 12-week regimenRead More"}